China Universal Asset Management Co., Ltd. Intellia Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 20,764 shares of NTLA stock, worth $190,198. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,764
Previous 21,596
3.85%
Holding current value
$190,198
Previous $251,000
41.43%
% of portfolio
0.01%
Previous 0.02%
Shares
17 transactions
Others Institutions Holding NTLA
# of Institutions
344Shares Held
98.4MCall Options Held
784KPut Options Held
713K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13MShares$119 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$98.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$87.9 Million0.0% of portfolio
-
State Street Corp Boston, MA4.51MShares$41.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.8MShares$34.8 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $696M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...